T1	condition 14 35	acute radiodermatitis
T2	intervention 39 57	photobiomodulation
T3	total-participants 513 516	120
T4	eligibility 517 583	BC patients that underwent an identical RT regimen post-lumpectomy
T6	control 646 653	placebo
T7	intervention-participants 666 668	60
T12	outcome 1644 1666	RTOG grade 2 or higher
T13	cv-bin-percent 1716 1719	30%
T14	iv-bin-percent 1724 1728	6.7%
T15	outcome 1911 1926	quality of life
T5	outcome 1775 1797	objective RISRAS score
T8	condition 394 402	acute RD
T11	outcome 2081 2107	grade 2 acute RD or higher
